Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development
Epilepsy is a serious neurological disorder that affects around 50 million people worldwide. Almost 30% of epileptic patients suffer from pharmacoresistance, which is associated with social isolation, dependent behaviour, low marriage rates, unemployment, psychological issues and reduced quality of...
Main Author: | Abdul Wahab |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/7/2090/ |
Similar Items
-
Anticonvulsant Properties of 1-Diethylamino-3-phenylprop-2-en-1-one
by: Swagatika Das, et al.
Published: (2023-09-01) -
Evaluation of magnetic resonance imaging-negative drug-resistant epilepsy
by: Aashit K Shah, et al.
Published: (2014-01-01) -
Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014-01-01) -
Deregulation of Astroglial TASK-1 K<sup>+</sup> Channel Decreases the Responsiveness to Perampanel-Induced AMPA Receptor Inhibition in Chronic Epilepsy Rats
by: Duk-Shin Lee, et al.
Published: (2023-03-01) -
Editorial: Burden of Illness in People With Epilepsy: From Population-Based Studies to Precision Medicine
by: Adam Strzelczyk, et al.
Published: (2019-01-01)